Pda Journal of Pharmaceutical Science and Technology
Overview
Pda Journal of Pharmaceutical Science and Technology is a scientific journal, published since 1994 in English. The journal's country of origin is United States and its primary focus area is pharmacology.
Details
Details
Abbr.
PDA J Pharm Sci Technol
Start
1994
End
Continuing
Frequency
Bimonthly
p-ISSN
1079-7440
e-ISSN
1948-2124
Country
United States
Language
English
Specialty
Pharmacology
Metrics
Metrics
h-index / Ranks: 8264
43
SJR / Ranks: 14452
152
CiteScore / Ranks: 11545
1.60
Recent Articles
1.
Ciolkowski M, Davis A, Harding A, Platzer S
PDA J Pharm Sci Technol
. 2025 Mar;
79(1):59-67.
PMID: 40032322
Topical ophthalmic solutions, suspensions, and emulsions are typically packaged in opaque or semi-transparent plastic dropper bottles. This packaging provides resistance to breakage and the controlled drop size needed in ophthalmic...
2.
3.
Zdravkovic S, Fu Q, Flick A, Jana B, Looney E, Kikandi S, et al.
PDA J Pharm Sci Technol
. 2025 Mar;
79(1):4-27.
PMID: 40032320
Substances that can be extracted () from the components of a medical device or a pharmaceutical product's manufacturing, packaging, and/or delivery system(s) are characterized as part of an extractable screening...
4.
Waldron K, McFarland A, Baseman H, Jornitz M
PDA J Pharm Sci Technol
. 2025 Mar;
79(1):88-97.
PMID: 40032319
In January 2023, ICH Q9 was updated to include expanded guidance on risk-based decision-making, emphasizing its application in informing science-driven and strategic decisions. The revised guidance highlights that while quality...
5.
Waldron K, McFarland A, Baseman H, Jornitz M
PDA J Pharm Sci Technol
. 2025 Feb;
PMID: 39929721
In January 2023, ICHQ9 was updated to include expanded guidance on risk-based decision-making, emphasizing its application in informing science-driven and strategic decisions. The revised guidance highlights that while quality risk...
6.
Ciolkowski M, Davis A, Harding A, Platzer S
PDA J Pharm Sci Technol
. 2025 Feb;
PMID: 39929720
Topical ophthalmic solutions, suspensions, and emulsions are typically packaged in opaque or semi-transparent plastic dropper bottles. This packaging provides resistance to breakage and controlled drop size needed in ophthalmic container...
7.
Fedorowicz F, Fedorowicz F, Zerr A, Mathaes R, Eisele M, Maas S, et al.
PDA J Pharm Sci Technol
. 2024 Dec;
79(1):28-58.
PMID: 39730203
The detectability size threshold of visible particles ("visibility" size) in the context of visual inspection of parenteral drug products has been an elusive target for several decades. The current common...
8.
Stassen M, Leitao C, Manzano T, Valero F, Stevens B, Schmucki M, et al.
PDA J Pharm Sci Technol
. 2024 Dec;
79(1):68-87.
PMID: 39730202
This review paper explores the transformative impact of Artificial Intelligence (AI) on Continued Process Verification (CPV) in the biopharmaceutical industry. Originating from the CPV of the Future project, the study...
9.
Jenke D, Christiaens P, Heise T
PDA J Pharm Sci Technol
. 2024 Dec;
79(1):98-113.
PMID: 39730201
Substances leached from a medical device during its clinical use are important due to the patient health-related effects they may have. Thus, medical devices are profiled for leachables (and/or extractables...
10.
Haglind A, Hakansson E, Wallmenius N, Hansson A, Isaksson K
PDA J Pharm Sci Technol
. 2024 Dec;
78(6):643-680.
PMID: 39725491
During a closed connected single-use monoclonal antibody (mAb) purification process, samples for leachables screening were gathered from two parallel processes (using different capturing chromatography), from perfusion culture to final storage...